Takeda Pharmaceutical (TAK) Return on Capital Employed Growth (5y) (2024 - 2026)
Takeda Pharmaceutical (TAK) Return on Capital Employed Growth (5y) (2024 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.55 Bn | 87.69 Bn | - |
| 2 | Teva Pharmaceutical Industries | 36.00 Bn | 32.26 Bn | 1.97 Bn |
| 3 | Zoetis | 32.59 Bn | 30.65 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.52 Bn | 23.45 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.07 Bn | 20.91 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - |
| 7 | Viatris | 20.28 Bn | 18.47 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.78 Bn | 16.47 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn |
| 10 | Vireo Growth | 10.51 Bn | 10.36 Bn | 59.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -616.00 |
| Dec 31, 2025 | -276.00 |
| Sep 30, 2025 | 70.00 |
| Jun 30, 2025 | 75.00 |
| Mar 31, 2025 | -120,663.00 |
| Sep 30, 2024 | -99,243.00 |
| Jun 30, 2024 | -161,467.00 |
| Mar 31, 2024 | -263,694.00 |